Status:
COMPLETED
Optimizing Care for Patients With Dementia
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Alzheimer Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Of the 1.4 million nursing home (NH) residents in long term care facilities, more than half have Alzheimer's disease or dementia. Due to changes in their familiar daily routines, difficulty expressing...
Eligibility Criteria
Inclusion
- Eligible nursing home facilities will
- lack any existing dementia program targeting reduction of off-label psychotropic medication use
- each serve \>60 long-term care residents with Alzheimer's or dementia
- meet Center for Medicare \& Medicaid Services' minimum requirements for NHs (e.g., meeting the mandated number of hours of staff training on dementia care, performing regularly scheduled resident assessments).
Exclusion
- Facilities will be excluded if they have
- less than 60 long-stay residents
- an existing formal dementia care program in place
- an off-label psychotropic medication reduction program
- is located in a state that requires more than the Center for Medicare \& Medicaid Services' minimum for staff training requirements on the topic of dementia care
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03442322
Start Date
March 15 2018
End Date
July 26 2022
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213